Poland· PL-100367252

Coaxil

A tianeptine product containing tianeptinum natricum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC N06AX14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCoaxilATCN06AX14REGISTER NO.PL-100367252PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Tianeptine is registered in 5 of 19 countries.

Countries holding a registration under ATC N06AX14 (tianeptine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Tianeptine · ATC N06AX14

5 / 19 countries

  • Czechiaprice
  • Franceprice
  • Germany
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tianeptine costs, country by country.

Normalised to the WHO defined daily dose (37.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tianeptine · price per daily dose (37.5 mg)

USD · FX 28 Sept 2026

  • FR France$0.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tianeptinum natricum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
N06AX14
ATC class
Tianeptine
Defined daily dose
37.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991267131
  • gtin
    05909991267148

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tianeptine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tianeptine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Stablon
  • Bulgaria · Коаксил
  • Czechia · Coaxil
  • Germany · Tianesan, Tianeurax
  • Estonia · Coaxil, Salymbra
  • Spain · Zinosal
  • France · Stablon, Tianeptine Biogaran
  • Greece · Tianeptine Liconsa
  • Croatia · Coaxil, Neptika
  • Hungary · Aneptinex, Coaxil
  • Lithuania · Coaxil
  • Luxembourg · Stablon
  • Latvia · Coaxil
  • Portugal · Neluptin, Stablon
  • Romania · Coaxil, Lyxit
  • Slovenia · Coaxil
  • Slovakia · Aneptinex, Coaxil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3108ecd-ab29-4cd4-9900-bab7cff3937d
GET /v1/drugs/e3108ecd-ab29-4cd4-9900-bab7cff3937d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "12,5 mg",
  "packaging": "05909991267131 ¦ Rp ¦ 114742\n30 tabl.\n05909991267148 ¦ Rp ¦ 114743\n90 tabl.",
  "substance": "Tianeptinum natricum 12.5 mg",
  "common_name": "Tianeptinum natricum",
  "pl_product_id": "100367252",
  "pozwolenie_nr": "164/16",
  "auth_procedure": "IR",
  "authorisation_validity": "2026-03-16"
}

See everything about tianeptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.